The WHO (World Health Organization) has provided many policies and benefits that encourage research and development by a pharmaceutical company to discover a molecule or drug that treats small and more complicated diseases. The different types of policies provided by the government are; pharmaceutical cost control policies, legal policies, investments, knowledge, expertise, modernization and management. The pharmaceutical industry must balance the difference between maximizing its profits and increasing health standards by decreasing the mortality rate and increasing the value of life. The main reason for the increased development of the pharmaceutical industries in Western Europe and the United States is due to the attention paid to them by the government in terms of investments. The government usually invests in research conducted in medical research institutes. So, to improve effectiveness, innovation and competition, the best way is to collaborate with private companies. In the year 2008-2011 the New Zealand government allocated $204.5 million for science and technology. But compared to the Organization for Economic Co-operation and Development (OECD), New Zealand's investment was on average (Lockhart,